GREYLOCK XII GP LLC
Follow13F filer, CIK 1413877, Menlo Park, CA
GREYLOCK XII GP LLC reported $142,038,000 across 4 holdings for the quarter ended 2018-09-30, in a 13F-HR filed 2018-11-01.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-18-010399
- Period
- 2018-09-30
- Reported value
- $142M
- Holdings
- 4
- Top 10 weight
- 100%
- New
- 2
- Sold out
- 0
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| KALA BIO INC COMnew | +199,613 | $1.97M |
| RYTMnew | +54,749 | $1.6M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
None.
Holdings, Q3 2018
Share positions as resolved from 13F-HR 0000950123-18-010399, largest first. % of portfolio is the value over $142,038,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| REDFIN CORPREDFIN CORP | 4,177,012 | $78.1M | 54.99% | 0 | |||
| CLOUDERA INCCLOUDERA INC | 3,419,865 | $60.4M | 42.5% | 0 | |||
| KALA BIO INC COMKALA BIO INC COM | 199,613 | $1.97M | 1.39% | new | |||
| RYTMRHYTHM PHARMACEUTICALS INC | 54,749 | $1.6M | 1.12% | new | Timeline |
How Q3 2018 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000950123-18-010399 | base | 2018-11-01 | acceptance time not in the bulk data set |